BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioNJ X-ORIGINAL-URL:https://bionj.org X-WR-CALDESC:Events for BioNJ REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20241024T170000 DTEND;TZID=America/New_York:20241024T190000 DTSTAMP:20260503T084719 CREATED:20241007T140338Z LAST-MODIFIED:20241023T114810Z UID:12860-1729789200-1729796400@bionj.org SUMMARY:Life Sciences Alternative Funding Panel DESCRIPTION:Join us at the New Jersey Bioscience Center for insights into alternative sources of funding to advance life sciences companies in New Jersey. \n\n\n\nThis panel discussion will focus on securing funding from non-traditional sources\, and will address the following questions: \n\n\n\n\nHow will the next generation of drugs\, diagnostics\, and devices be funded?\n\n\n\nWhat new models are there that might change the paradigm?\n\n\n\nIs there a better way to fund early and emerging commercial biomedical research?\n\n\n\n\nPanelists Include: \n\n\n\n\nJosh Barer\, Managing Director at Hibiscus BioVentures\n\n\n\nJudith Sheft\, Executive Director\, NJ CSIT\n\n\n\nJorge Ramirez\, Vice President\, M&A and Business Development\, Quest Diagnostics\n\n\n\n\nModerated by John Pennett\, Partner\, Life Sciences and Technology Group\, Eisner Advisory Group LLC URL:https://bionj.org/event/life-sciences-alternative-funding-panel/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241022T120000 DTEND;TZID=America/New_York:20241022T130000 DTSTAMP:20260503T084719 CREATED:20240926T131152Z LAST-MODIFIED:20240926T131327Z UID:12772-1729598400-1729602000@bionj.org SUMMARY:Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness DESCRIPTION:Positioning Early Cell Therapy for Clinical Success: Mitigating Risk & Ensuring GMP Readiness\n\n\n\nTuesday\, October 22\, 2024 | 12:00 p.m.-1:00 p.m. | Virtual \n\n\n\n\nREGISTER TODAY FOR FREE!\n\n\n\n\nThe promise of cell therapies is often tempered by the many complexities of transitioning these innovations from R&D to the clinic. For early phase programs\, there are many aspects to consider\, from understanding evolving regulatory guidelines and reviewimg pathway options to addressing common manufacturing-related issues such as scalability\, high cost of goods\, and workforce retention. Additionally\, organizing and executing a successful cell therapy clinical trial can be challenged by a limited number of qualified clinical sites with experience in conducting advanced therapy studies\, access to desired Patient populations\, and managing the complex supply chain required to deliver therapies to Patients in a timely fashion. \n\n\n\nThrough a series of brief presentations on three key topic areas\, this webinar will help early phase cell therapy developers identify insights to mitigate risk and ensure clinical readiness to position their programs for success. \n\n\n\nSpecific topic areas of focus include: \n\n\n\n\nNavigating an evolving cell therapy regulatory landscape\n\n\n\nHow to assess GMP-readiness and prepare your cell therapy workflow for clinical and commercial manufacturing\n\n\n\nEnsuring patient-centricity in the complex cell therapy ecosystem and leveraging a unique\, comprehensive operating model for your product\n\n\n\n\nLearning objectives: \n\n\n\n\nStrategies to navigate regulatory hurdles and maximize impact of meetings with regulators\n\n\n\nBest practices to address common challenges in cell therapy process development and manufacturing\n\n\n\nOpportunities for a more streamlined\, Patient-centric approach to cell therapy clinical trials\n\n\n\nBenefits of working with an integrated CRO/CDMO partner to simplify the cell therapy value chain and improve Patient-centricity\n\n\n\n\nPresenters: \n\n\n\n\nMichele DugganSr. Manager\, Regulatory AffairsThermo Fisher Scientific  \n\n\n\nMs. Duggan joined Thermo Fisher Scientific in 2021 as Sr. Manager Regulatory Affairs supporting the development and delivery of regulatory solutions for customers within the biologics and advanced therapies pharma services manufacturing network. Prior to joining Thermo Fisher Scientific\, she spent over 17 years in CMC regulatory consulting\, providing regulatory strategy\, dossier authoring and review expertise for biologics and cell therapy products across all stages of the product life cycle. \n\n\n\n\n\n\n\n\n\nMindy Sadik\, Ph.D.Director\, Cell Therapy SciencesThermo Fisher Scientific  \n\n\n\nDr. Sadik oversees the Process Development and Analytical Development teams for the Cell Therapy Business unit for Advanced Therapies. Dr. Sadik’s teams work closely with partners to provide development and clinical scale services\, which include gene and non-gene modified cell processing for autologous and allogeneic cell therapies. This work includes technology transfer from the client to Thermo Fisher’s site\, process optimization and workflow readiness for transition into GMP manufacturing.  \n\n\n\n\n\n\n\n\n\nKim Watanabe\, Ph.D.Executive Director\, Cell and Gene Therapy Pillar HeadThermo Fisher Scientific  \n\n\n\nDr. Watanabe recently joined PPD\, part of Thermo Fisher Scientific\, where she leads business and operational strategy development and deployment in hematology and oncology clinical development services. She has 20 years of experience in R&D\, business and operations\, of which the last 14 years have been focused on cell and gene therapies. Prior to her current role\, Dr. Watanabe served as General Manager and Site Head for the Patheon Translational Services. Prior to her current role\, she served as GM/ Site Head for the Patheon Translational Services\, part of the contract development and manufacturing organization of Thermo Fisher Scientific. \n\n\n\n\n\n\n\n\nRegister today and join us on October 22 for this FREE educational webinar. Come ready to learn and ask questions! URL:https://bionj.org/event/positioning-early-cell-therapy-for-clinical-success-mitigating-risk-ensuring-gmp-readiness/ LOCATION:New Jersey END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241010T073000 DTEND;TZID=America/New_York:20241010T163000 DTSTAMP:20260503T084719 CREATED:20240318T181526Z LAST-MODIFIED:20241002T120610Z UID:11216-1728545400-1728577800@bionj.org SUMMARY:2024 BioNJ C-Suite Summit DESCRIPTION:THIS EVENT IS CLOSED TO THE MEDIA \n\n\n\nAn Inflection Point for Innovation in Life Sciences\n\n\n\nThursday\, October 10\, 2024 | 7:30 a.m.-4:30 p.m. Bridgewater Marriott\, 700 Commons Way\, Bridgewater\, NJ \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nAgainst a backdrop of change\, the biopharmaceutical industry – and the next wave of innovation – are at an inflection point. Join us to reflect on the state of innovation in life sciences and how companies can best navigate through this period of continued change. \n\n\n\n \n \n \n \n \n \n\n TimeAGENDA\n\n\n\n \n 7:30 a.m. – 8:15 a.m.Registration & Networking Breakfast \n \n \n8:15 a.m. – 8:20 a.m.\n\n Welcome & Opening Remarks \n\nDebbie Hart\, President & CEO\, BioNJ\nEmer Leahy\, MBA\, Ph.D.\, President & CEO\, PsychoGenics & Chair\, BioNJ\n\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeINNOVATION\n\n\n\n \n \n8:20 a.m. – 8:50 a.m.\n\nKeynote: The Next Wave of Innovation in Life Sciences \nLife sciences leaders are navigating a period of exciting innovation. Novel modalities and mechanisms of action have helped the industry address previously stubborn unmet needs. Over the past 10 years\, R&D spend has increased\, the pipeline has become more diverse and new asset approvals have accelerated. Looking ahead\, policy reforms (e.g.\, IRA)\, a rapid proliferation in technological resources (e.g.\, AI\, mRNA platforms) and a rise in cross-company collaborations suggest further change and opportunity. Join us in reflecting on what the future of life sciences innovation holds\, and implications for large cap pharma companies\, biotechs and life sciences investors.  \n\nBrandon Parry\, MBA\, Sr. Partner\, McKinsey & Company\n\n \n \n \n8:50 a.m. – 9:45 a.m.\n\nPanel: Harnessing Change to Deliver Impactful Innovation \nIndustry leaders will reflect on the state of innovation\, expected industry shifts\, latest thinking on development paradigms\, portfolio shifts\, the lasting implications of policy reforms\, the impact of technological evolutions\, talent priorities and more. \n\nGarrett Ingram\, President & CEO\, Cipla Therapeutics\nWill Lewis\, MBA\, J.D.\, Chair & CEO\, Insmed\nClive Meanwell\, M.D.\, Chair & Partner\, Population Health Partners\nTarek Rabah\, MBA\, President & CEO\, Otsuka Pharmaceuticals\nScott White\, MBA\, Chief Operations Officer\, NA Innovative Medicine\, Johnson & Johnson\nConversation Leader: Harriet Keane\, Ph.D.\, Partner\, McKinsey & Company\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimePOLICY\n\n\n\n \n \n9:45 a.m. – 10:15 a.m.\n\nFireside Chat: Policy Uncertainties in an Election Year \nThe past 18 months have borne witness to a rapidly evolving policy landscape (including but not limited to the IRA\, IP\, BIOSECURE) – with expected evolutions on the horizon compounded by a tumultuous election season. With the presidential election just a few weeks away\, this session will explore potential health policy changes and implications for industry leaders. \n\nHon. Jim Greenwood\, Former Congressman & Former President & CEO\, BIO \nHeather Meade\, Principal\, EY\nConversation Leader: Lisa LeCointe-Cephas\, J.D.\, Partner\, Compliance & Investigations & Global Chair\, Life Sciences Sector\, DLA Piper\n\n \n \n 10:15 a.m. – 10:30 a.m.\nNetworking Break \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeMARKET ACCESS\n\n\n\n \n 10:30 a.m. – 11:15 a.m.\nPanel: Market Access & ReimbursementThe market access landscape is intricate and constantly evolving\, with payers persistently refining their business models and strategies. This panel will explore the essential groundwork for securing optimal reimbursement and payer coverage\, which are crucial for ensuring Patient access to treatments and\, ultimately\, improving Patient care. The panel will also address key issues manufacturers face including changing legislation\, consolidation\, M&A\, gross to net and commercial launch planning. \n\nPaul Hunter\, Vice President\, Market Access and Commercial Operations\, Halozyme\nChristopher Jackson\, J.D.\, Managing Member\, The Law Office of Christopher S. Jackson\nJake McDowell\, Vice President\, Head\, Market Access\, Pricing and Value\, Partner Therapeutics\nConversation Leader: Tom Evegan\, Principal\, Strategy & Management Consulting; National Consulting Leader Life Sciences\, RSM\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeTALENT\n\n\n\n \n 11:15 a.m. – 12:00 p.m.\nPanel: Topics in Talent: Attraction\, Retention & DiversityIn the life sciences sector\, talent development is crucial for fostering innovation and addressing complex challenges. Companies are focused on developing the next generation of talent by providing opportunities for education\, training and mentorship. Additionally\, there is a growing emphasis on upskilling and reskilling talent to leverage AI and other advanced technologies for greater efficiency and effectiveness. This discussion will explore key learnings from workplace evolutions and strategies companies can and must adopt such as equity. \n\nBritt Byers\, Executive Vice President\, Human Resources NA\, Kyowa Kirin\nVikki Conway\, Sr. Vice President & Head\, Human Resources\, U.S.\, Teva Pharmaceuticals\nKiran Dattani\, MPH\, MBA\, Customer Success\, Transformation\, Strategy & Architecture\, Google Cloud Healthcare & Life Sciences\, Google\nConversation Leader: Jan Campbell\, Managing Partner Pharmaceuticals & Biotechnology\, Korn Ferry\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeRESEARCH & DEVELOPMENT\n\n\n\n \n 12:00 p.m. – 12:30 p.m.\nFireside Chat: Research & Development in Mental HealthWith Global Mental Health Day as the backdrop\, this discussion features two pioneers in mental health research and development and will explore the challenges in developing therapeutics in the mental health space and how they can provide learnings in other areas. \n\nHusseini Manji\, M.D.\, F.R.C.P.C.\, Professor\, Oxford University; Co-Chair\, UK Govt MH Mission; Former Global Head\, Neuroscience\, Janssen/Johnson & Johnson\nConversation Leader: Emer Leahy\, MBA\, Ph.D.\, President & CEO\, PsychoGenics & Chair\, BioNJ\n\n \n \n 12:30 p.m. – 1:30 p.m.\nNetworking Lunch \n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeCOMMERCIALIZATION & PATIENT SERVICES\n\n\n\n \n 1:30 p.m. – 2:15 p.m.\nPanel: Continued Evolutions in Go-to-Market Models Including Patient ServicesThe continued evolution of the go-to-market (GTM) commercial model in life sciences has been characterized by a shift from push to pull strategies\, the development of novel roles that rethink traditional functional boundaries in a compliant manner\, and a simplification of the customer interface. This talk will explore how these approaches can enhance and improve Patient access to treatments given the complex journey that is the Patient experience. Getting it right can have a major impact on Patient outcomes\, as Patient experience in healthcare continues to lag. personalized journeys. \n\nJohn Harlow\, Chief Commercial Officer\, Melinta Therapeutics\nRohan Jain\, General Manager\, Commercial\, Nusano\nGina Murdoch\, MBA\, President & CEO\, Multiple Sclerosis Association of America\nConversation Leader: Haripriya Jain\, MS\, MBA\, Executive Director\, Global Value & Access Consulting\,  Evidera\, part of Thermo Fisher Scientific \n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeCAPITAL MARKETS\n\n\n\n \n 2:15 p.m. – 3:00 p.m.\nPanel: Evolving Capital Markets & Implications for InnovationThe life sciences industry market cap has more than tripled in a decade despite more recent challenges. This discussion will explore the latest funding environment (e.g.\, IPOs) and implications for industry. \n\nAamir Mecklai\, Managing Director\, Healthcare Investment Banking\, Bank of America\nChristopher Mortko\,MBA\, Ph.D.\, Vice President\, Business Development & Licensing\, Merck & Co.\nMonika Vnuk\, M.D.\, Sr. Vice President\, Global Partnering & Business Development\, Sanofi\nConversation Leader: Arda Ural\, MBA\, Ph.D.\, Americas Life Sciences Sector Leader\, EY\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n\n TimeAI & TECHNOLOGY\n\n\n\n \n 3:00 p.m. – 3:45 p.m.\nPanel: The Digital & AI Era in the Biopharma Industry: How Can Companies Across Functions Transition from Hype Into Reality?In the current environment\, the biopharmaceutical industry is experiencing a transformative shift towards digitalization and AI adoption\, promising improved efficiency\, innovation and Patient outcomes. However\, for companies to transition successfully from the hype surrounding these technologies into tangible benefits\, they must integrate digital and AI solutions across functions\, prioritize data-driven decision-making and foster a culture of innovation and adaptability. \n\nSydney Klein\, Chief Information Security Officer & Head of IT Core Services\, Bristol Myers Squibb\nHisham Hamadeh\, Ph.D.\, Sr. Vice President & Global Head\, Data Science & AI\, Genmab\nKeith Koharski\, MBA\, Executive Director\, Global Development IT\, Regeneron\nDeiva Ramachandran\, Ph.D.\, Partner\, Generative AI-Automation Practice Leader\, Healthcare\, Life Sciences\, State & Local Government\, IBM\nConversation Leader: Donna Conroy\, Founder\, CEO\, SciMar ONE\n\n \n \n \n \n \n \n\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nJoin us on October 10 for this important conversation. Registration is $695 for BioNJ Members and $895 for Future Members. (BioNJ is pleased to have maintained our pricing unchanged for the past three years.) Click here to register. \n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/2024-bionj-c-suite-summit/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/03/CSuite-Summit-2024.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240926T120000 DTEND;TZID=America/New_York:20240926T133000 DTSTAMP:20260503T084720 CREATED:20240719T135506Z LAST-MODIFIED:20240829T163911Z UID:12354-1727352000-1727357400@bionj.org SUMMARY:AI & Digital Health Webinar DESCRIPTION:The Path to Real Impact of AI on Healthcare and Life Sciences\n\n\n\nThursday\, September 26\, 2024 | 12:00 p.m.-1:30 p.m. | Virtual \n\n\n\n\nREGISTER TODAY FOR FREE!\n\n\n\n\nJoin us on September 26 for a complimentary webinar\, where leading industry experts will share insights into how they are leveraging AI and cutting-edge technology to drive innovation\, expand access and enhance Patient outcomes. Don’t miss this opportunity to gain valuable knowledge from those at the forefront of transformative advancements. \n\n\n\nSpeakers Include: \n\n\n\n\nKiran DattaniCustomer SuccessTransformation\, Strategy & Architecture Google Cloud \n\n\n\nMr. Dattani is a seasoned AI Specialist & Technologist with over 20 years of experience in the life sciences and pharmaceutical industries. He has a proven track record of driving AI & digital transformation\, automation and data science initiatives for leading organizations like Pfizer and Google. Mr. Dattani’s expertise spans AI healthcare practice\, enterprise architecture\, cloud enablement\, AI and data solution delivery. He has a passion for leveraging technology to improve Patient outcomes. \n\n\n\n\n\n\n\n\n\nSeemi KazmiExecutive DirectorProduct Management\, Digital HealthBristol Myers Squibb \n\n\n\nMs. Kazmi is Executive Director and Digital Health TA Lead for Cardiovascular and Neuroscience. She is responsible for defining digital health strategy and implementing innovative solutions across the pharma value chain\, both in commercial and clinical development. Ms. Kazmi is responsible for the global roadmap of a portfolio of solutions that includes first-in-class AI-based algorithms for Patient identification and clinical decision support\, biometric sensors/wearables for remote Patient monitoring\, tools integrated into EMRs and novel digital biomarkers of disease. \n\n\n\n\n\n\n\n\n\nScott OgdenHead\, AI LabsGenmab \n\n\n\nMr. Ogden heads up the AI Innovation Lab at Genmab\, where he’s focused on bringing leading\, novel solutions to the forefront of biotech. With a background in computation\, Mr. Ogden has spent his working years building healthcare innovation teams across the different sectors\, including payors and providers. He’s currently juggling his role at Genmab with working on his EMBA at Wharton\, studying entrepreneurship. During the program\, he will share some down-to-earth insights on how Genmab is using AI to push the envelope on the end-to-end drug development lifecycle. \n\n\n\n\n\n\n\n\n\nTroy Sarich\, Ph.D.Chief Commercial Data Science OfficerJohnson & Johnson Innovative Medicine \n\n\n\nDr. Sarich leads teams that leverage the power of artificial intelligence and machine learning\, real-world evidence (RWE)\, digital health and precision medicine across J&J’s global regions and multiple therapeutic areas. During his nearly 20-year tenure at J&J\, Dr. Sarich has delivered business transformation and Patient impact across the Innovative Medicine sector’s R&D and Commercial teams\, including as Vice President\, RWE\, Global Head of R&D Strategy\, founding co-chair and member of the J&J AI Council and in pivotal roles in the clinical development of INVOKANA® and XARELTO®. \n\n\n\n\n\n\n\n\nBioNJ is building a Directory of AI Service Providers. If you are a BioNJ Member and fit into this category\, send your company information to RBromberg@BioNJ.org! URL:https://bionj.org/event/ai-digital-health-webinar/ LOCATION:New Jersey ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/07/Digital-Health-Webinar.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240913T083000 DTEND;TZID=America/New_York:20240913T154500 DTSTAMP:20260503T084720 CREATED:20240501T201159Z LAST-MODIFIED:20240912T152127Z UID:11637-1726216200-1726242300@bionj.org SUMMARY:2024 BioNJ Manufacturing Briefing DESCRIPTION:Building the Future: Advancing Capabilities\, Technology and Talent for the Next Era of Biomanufacturing\n\n\n\nFriday\, September 13\, 2024 | 8:30 a.m.-3:45 p.m. Sanofi\, 55 Corporate Dr\, Bridgewater\, NJ \n\n\n\nRegistration is now closed for this event. We look forward to seeing everyone tomorrow at the program. Please contact Maria Carapucci at MCarapucci@BioNJ.org with any questions. Thank you.  \n\n\n\nBiopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry. URL:https://bionj.org/event/2024-bionj-manufacturing-briefing/ LOCATION:Sanofi\, 55 Corporate Dr\, Bridgewater\, New Jersey\, 08807\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240627T120000 DTEND;TZID=America/New_York:20240627T131500 DTSTAMP:20260503T084720 CREATED:20240523T201528Z LAST-MODIFIED:20240711T141128Z UID:11913-1719489600-1719494100@bionj.org SUMMARY:2024 BioNJ IT/Cyber Briefing Webinar DESCRIPTION:FREE Webinar: De-Risking Cybersecurity forEmerging Life Sciences Companies \n\n\n\nThursday\, June 27\, 2024 | 12:00 p.m.-1:15 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin BioNJ’s IT/Cybersecurity Awareness Committee on June 27 for a virtual discussion on “De-risking Cybersecurity for Emerging Life Sciences Companies.” Few industries are as heavily targeted by cybercriminals as life sciences. It’s easy to see why…given the immense value of Patient data\, research\, market insights and product information. And emerging life sciences companies face even greater risks\, as they often have limited operational budgets for cybersecurity personnel and infrastructure. \n\n\n\nDuring this content-dense webinar\, we’ll hear from current life sciences CEOs\, CFOs and CIOs about the real-world cybersecurity challenges facing emerging companies. Additionally\, cybersecurity industry experts — including the FDA — will share some of the practical ways to address those challenges.  \n\n\n\nRegister today and come ready to ask our experts questions. \n\n\n\nHear from These Thought Leaders\n\n\n\n\n\n\n\n\n\nJim AmbrosiniChief InformationSecurity OfficerCompassMSP \n\n\n\n\n\n\n\n\n\nSusan BlumChief Financial OfficerMelinta Therapeutics \n\n\n\n\n\n\n\n\n\nDaniel BurkeDivision Chief\, Cyber OperationsOffice of Criminal InvestigationsU.S. Food and DrugAdministration \n\n\n\n\n\n\n\n\n\nPaul FangSr. Director\, InformationSecurity & ComplianceBeiGene \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRandy MilbyCEO & ChairTharimmune \n\n\n\n\n\n\n\n\n\nMark PelligrinoSr. Vice PresidentChief Information OfficerInsmed \n\n\n\n\n\n\n\n\n\nChris RiosSr. Vice PresidentMarsh \n\n\n\n\n\n\n\n\n\nModeratorLarry SamilowCo-Founder & Managing DirectorVerve Group Consulting \n\n\n\n\n\nThank You to Our Sponsors URL:https://bionj.org/event/bionj-it-cyber-briefing-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2024/05/IT-Cyber.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240618T083000 DTEND;TZID=America/New_York:20240618T153000 DTSTAMP:20260503T084720 CREATED:20240318T175837Z LAST-MODIFIED:20240613T163705Z UID:11210-1718699400-1718724600@bionj.org SUMMARY:2024 BioNJ HR Conference DESCRIPTION:Flourishing at Work: Tools\, Tips\, and Trends \n\n\n\nTuesday\, June 18\, 2024 | 8:30 a.m.-3:30 p.m. \n\n\n\nKean University\, 1000 Morris Ave.\, Union\, NJ \n\n\n\nThis program is approved for 5.5 HR Certification Institute® (HRCI®) credits. \n\n\n\nJoin us for BioNJ’s 11th Annual HR Conference\, taking place at Kean University on June 18. Come ready to connect with other life sciences HR professionals\, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.  \n\n\n\nBe part of the conversation. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem. \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\nLynne Anderson\, J.D.PartnerFaegre Drinker \n\n\n\n\n\n\n\n\n\nBrenda BurnerDirector\, Global CompensationMerck & Co. \n\n\n\n\n\n\n\n\n\nChristopher CozicExecutive Vice President & Chief People OfficerGenmab \n\n\n\n\n\n\n\n\n\nAndrew DicksonPrincipalMercer \n\n\n\n\n\n\n\n\n\nD’Angelique DopsonDirector Total Rewards Human ResourcesShionogi \n\n\n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nDawn KesslerDirector\, Site HR Lead USGenmab \n\n\n\n\n\n\n\n\n\nStela LupushorChief-Reframer\, Reframe.Work Inc. & Co-Author of “Humans at Work and Humanizing Human Capital” \n\n\n\n\n\n\n\n\n\nEileen McNeelyPh.D.\, M.S.\, R.N.Executive Director SHINE\, Human Flourishing ProgramHarvard University \n\n\n\n\n\n\n\n\n\nSally PaullExecutive Vice President Chief Human Resource OfficerRegeneron \n\n\n\n\n\n\n\n\n\n\n\nBetty Rivera-ManningRewards Business Partner/ US P&O Policy Lead Novartis \n\n\n\n\n\n\n\n\n\nDerrick Swinton\, Ph.D. Associate Dean for Research\, Dorothy and George Hennings College of Mathematics\, Science and TechnologyKean University \n\n\n\n\n\n\n\n\n\nLisha YangSenior Director\, Head of Operations Data Science & AIGenmab \n\n\n\n\n\n \n\n\n\n\n\n \n\n\n\n\n\nCome ready to gather new and creative ideas\, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.  \n\n\n\nClick here to register now. Registration is $195 for BioNJ Members and $295 for Future Members. To learn about Sponsorship opportunities\, contact Cheri Hennessy at CHennessy@BioNJ.org or 609-890-3185.  \n\n\n\n\n\n\n\n\n\n\nDownload Kean Campus Map URL:https://bionj.org/event/2024-bionj-hr-conference/ LOCATION:Kean University\, 1000 Morris Ave\, Union\, New Jersey\, 07083\, United States CATEGORIES:BioNJ Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240521T120000 DTEND;TZID=America/New_York:20240521T131500 DTSTAMP:20260503T084720 CREATED:20240419T194030Z LAST-MODIFIED:20240520T183739Z UID:11558-1716292800-1716297300@bionj.org SUMMARY:Capital Markets Update / State of the Economy DESCRIPTION:FREE Webinar: Capital Markets Update / State of the Economy \n\n\n\nTuesday\, May 21\, 2024 | 12:00 p.m.-1:15 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this insightful webinar where we’ll dive into crucial topics shaping the financial landscape. Our experts will discuss M&A collaborations and deals\, emerging technologies garnering funding and the impacts of the IRA. Plus\, you’ll gain valuable insights into the upcoming 2024 election’s potential ramifications on the economy. Don’t miss this opportunity to stay ahead in today’s dynamic market environment. Topics include: \n\n\n\n\nM & A Collaborations & Deals\n\n\n\nTechnologies that are being funded and those that are not\n\n\n\nIRA and its Impacts \n\n\n\nUpcoming 2024 Election\n\n\n\n\nSpeakers: \n\n\n\n\nKeith Gaub \n\n\n\nVice President & Assistant TreasurerBristol Myers Squibb \n\n\n\nMr. Gaub oversees Capital Markets\, Financial Risk Management\, International Treasury & International Treasury Operations\, Cash Leadership and Benefit Investments.  Prior to joining BMS\, he worked at Zoetis for nine years\, most recently serving as Senior Director of Investor Relations\, where he managed relationships with sell-side analysts and large institutional investors\, in addition to supporting their CEO and CFO during earnings announcements. \n\n\n\n\n\n\n\n\n\nCourtney Rickert McCaffrey \n\n\n\nGlobal Insights LeaderEY Geostrategic Business Group \n\n\n\nMs. McCaffrey drives market-leading insight around geopolitics\, corporate performance and political risk management. She leads the analysis of the annual EY Geostrategic Outlook and advises clients on how geopolitical developments may impact their companies’ operations and strategies\, and how to manage political risks more proactively. She is also the co-author of a forthcoming book entitled Geostrategy by Design: How to Manage Geopolitical Risk in the New Era of Globalization. \n\n\n\n\n\n\n\n\n\nPatrick Morley \n\n\n\nSenior Managing Director Equity Capital MarketsLeerink Partners \n\n\n\nMr. Morley is a Senior Managing Director in Leerink Partners’ Equity Capital Markets group\, advising private and public healthcare companies on the optimal strategy and tactics to achieve their financing goals. He joined the Firm in 2011 as a member of the Healthcare Investment Banking group before transitioning to his current role.  \n\n\n\n\n\n\n\n\n\nPhilip Sclafani \n\n\n\nPartnerPWC \n\n\n\nMr. Sclafani has deep experience supporting branded\, biotech\, generics\, medical device and other healthcare companies. He leads high performing teams to address his clients most challenging issues across strategy\, operations\, digital & analytics\, compliance and technology in the Pharma commercial organization\, medical affairs\, M&A / business development and other key functions. \n\n\n\n\n\n\n\n\n\nRoel van den Akker \n\n\n\nPharmaceutical and Life Sciences Deals LeaderPWC \n\n\n\nMr. van den Akker is PwC’s Pharmaceutical and Life Sciences Deals Leader\, with vast experience in transactions\, deals\, M&A and divestitures. He leads a team focused on helping pharma\, life sciences and med tech companies win through deals and seamlessly capture value during acquisitions. \n\n\n\n\n\n\n\n\n\nMODERATOR: Scott Megaffin \n\n\n\nPresident & CEOAdiso Therapeutics \n\n\n\nLeveraging his extensive experience as a biopharma senior executive\, Mr. Megaffin has guided both public and private companies as CEO and Board Director. His deep knowledge spans a broad range of therapeutic areas\, including immunology\, inflammation\, oncology\, anti-infectives\, pain\, critical care and virology. He currently applies his expertise beyond Adiso by serving on the board of BioNJ and Adastra. \n\n\n\n\n\n\n\n\n\n\n\nWhether you’re involved in M&A\, technology\, finance or in the broader economic landscape\, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost. \n\n\n\nWho should attend this webinar: This webinar is ideal for financial professionals\, investors\, business leaders\, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy. URL:https://bionj.org/event/capital-markets-update-state-of-the-economy/ LOCATION:New Jersey CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240513T073000 DTEND;TZID=America/New_York:20240517T170000 DTSTAMP:20260503T084720 CREATED:20231218T161943Z LAST-MODIFIED:20231220T184516Z UID:9936-1715585400-1715965200@bionj.org SUMMARY:2024 BioPartnering Conference DESCRIPTION:IN-PERSON PARTNERING\, EDUCATION & NETWORKING: Tuesday\, May 14\, 2024 | 7:30 a.m.-5:45 p.m.The Palace at Somerset Park\, Somerset\, NJ 08873Virtual Partnering: Monday\, May 13 & Wednesday-Friday*\, May 15-17\, 2024Registration for BioNJ Members is $425 and $525 for Future Members. *Full Conference Registration Required. \n\n\n\n\n\n\nBecome a Sponsor\n\n\n\n\n\n\n\n\nSave the date and plan to join us on May 14\, 2024 for BioNJ’s 14th Annual BioPartnering Conference\, the premier partnering event for entrepreneurs looking to connect with investors and biopharmaceutical companies for funding and collaboration opportunities. \n\n\n\nOur new Conference location ― the Liberty Science Center ― offers a spacious\, state-of-the-art venue to accommodate the important and numerous elements of the Conference\, including: \n\n\n\n\n1-1 partnering\n\n\n\nCompany and start-up pitch presentations\n\n\n\nIndustry Connections (office hours with top biopharmaceutical companies)\n\n\n\nExhibits\n\n\n\nPlenary sessions\n\n\n\nAnd lots of networking\n\n\n\n\nBioNJ’s BioPartnering Conference attracts life sciences executives\, investors\, academic collaborators and business development professionals from around the globe ― with the goal of fostering productive partnerships and facilitating investment opportunities. \n\n\n\nApplications for Company Pitch Presentations for the 2024 BioNJ BioPartnering Conference will open January 16\, 2024. Be on the lookout for email notifications. URL:https://bionj.org/event/2024-biopartnering-conference/ LOCATION:Liberty Science Center\, 222 Jersey City Blvd\, New Jersey\, 07305\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange,Past Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/12/BioP-Color.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240327T120000 DTEND;TZID=America/New_York:20240327T130000 DTSTAMP:20260503T084720 CREATED:20240220T153351Z LAST-MODIFIED:20240315T150421Z UID:10856-1711540800-1711544400@bionj.org SUMMARY:Top Priorities for Life Sciences CFOs in 2024: A Life Sciences CFO Roundtable DESCRIPTION:FREE Webinar: Top Priorities for Life Sciences CFOs in 2024: A Life Sciences CFO Roundtable \n\n\n\nQualifies for 1.0 CPE Credit in Specialized Knowledge. \n\n\n\nWednesday\, March 27\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin BioNJ and BDO on Wednesday\, March 27 for a roundtable discussion with life sciences CFOs about opportunities and risks facing the industry in 2024. \n\n\n\nThe webinar will discuss BDO’s 2024 Life Sciences CFO Outlook Survey\, which polled life sciences CFOs on their expectations for 2024. Below are some of the key issues this webcast will address. \n\n\n\n\nReview how life sciences CFOs are adjusting their cash management and investing strategies in response to ongoing economic volatility.\n\n\n\nDiscuss what tax strategies life sciences CFOs are pursuing to improve their financial standing — and what opportunities they may be missing.\n\n\n\nDescribe the treatments and drug modalities that life sciences CFOs will be prioritizing in 2024.\n\n\n\nExplain how life sciences organizations are addressing generative AI risks and concerns\, especially those related to data privacy.\n\n\n\n\nWho should attend: Private and Public Company Controllers\, Vice Presidents of Finance\, CFOs\, R&D Company CEOs\, Finance Team Members and Legal Counsel and others who are interested in the life sciences ecosystem. \n\n\n\nPanelists: \n\n\n\n\n\n\n\n\nAmit BhallaExecutive Vice President & Chief Financial Officer\, Sampled \n\n\n\nMr. Bhalla has more than 25 years of Wall Street and healthcare industry experience. His background in finance\, strategy and business development includes experience in equity investing as well as sourcing\, negotiating and integrating transformational and tuck-in M&A. Most recently\, Mr. Bhalla served as Senior Healthcare Analyst at Lord\, Abbett & Co. with responsibility for investments across all healthcare verticals in seven Lord Abbett funds. \n\n\n\n\n\n\n\n\n\nMike MaddenChief Financial Officer\, Lumanity \n\n\n\nMr. Madden is responsible for the Lumanity’s financial operations and functions. This includes financial strategy\, financial performance management\, capital allocation\, financial services\, controllership\, tax\, treasury and corporate strategy. Mr. Madden joined Lumanity in 2023 as an experienced finance leader\, with over 20 years of global finance and transformation experience. He possesses a proven track record of success with Fortune 250 financial institutions\, large multinational\, public\, and private equity backed companies. \n\n\n\n\n\n\n\n\n\nHarry PalminExperienced CFO \n\n\n\nMr. Palmin has a successful track record of building\, financing and operating public/private life sciences companies for 25 years\, having taken 3 companies public. He served as CFO at Acer Therapeutics from 2016 until the sale to Zevra Therapeutics in November 2023. Mr. Palmin took Acer public in 2017 achieving a $330 million peak market capitalization and raised $172 million in pursuit of Acer’s drug development and commercial objectives culminating in OLPRUVA® approval in December 2022. \n\n\n\n\n\n\n\n\n\nSarah RomanoCPA\, Chief Financial Officer\, First Wave BioPharma \n\n\n\nBefore joining First Wave BioPharma in March 2022\, Ms. Romano held the position of Chief Financial Officer at Kiora Pharmaceuticals\, a clinical-stage specialty pharmaceutical company focused on ophthalmic disease treatments\, from February 2017 to February 2022. Earlier\, she served as Corporate Controller at Kiora Pharmaceuticals from August 2016 to January 2017. Prior to that\, Ms. Romano worked as an Assistant Controller at TechTarget and as Corporate Controller at Bowdoin Group\, a healthcare-oriented executive recruitment firm. \n\n\n\n\n\n\n\n\n\nModerator \n\n\n\nDouglas E. Gustin\, CPAAssurance Principal\, BDO \n\n\n\nMr. Gustin has over 20 years of combined experience in public and private accounting working primarily with middle-market companies in technology\, manufacturing and life sciences industries. His client service experience includes working on SEC engagements\, including accelerated and large accelerated issuers as well as private equity\, venture backed and family-owned businesses. Mr. Gustin has extensive experience working with other BDO International member firms. \n\n\n\n\n\n\n\n\nThe life sciences industry is changing. Learn what opportunities and risks could await life sciences companies in 2024 and how to plan ahead. \n\n\n\nWe hope to see you on March 27\, 2024 for this FREE educational webinar. URL:https://bionj.org/event/bdos-life-sciences-cfo-outlook-survey-live-sciences-resets-and-refocuses/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240306T120000 DTEND;TZID=America/New_York:20240306T130000 DTSTAMP:20260503T084720 CREATED:20240130T152008Z LAST-MODIFIED:20240130T152134Z UID:10742-1709726400-1709730000@bionj.org SUMMARY:Integrating AI and Robotics to Discover New Drugs Faster DESCRIPTION:FREE Webinar: Integrating AI and Robotics to Discover New Drugs Faster \n\n\n\nWednesday\, March 6\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this one-hour webinar where experts will use Iktos’ AI-driven platform to explore the synergy between artificial intelligence and robotics in the design and synthesis of novel molecules for drug discovery and optimization.  \n\n\n\nFrom handling diverse molecules\, reactions and exit vectors to optimizing reactants\, procedures and the number of steps\, this groundbreaking approach is poised to reshape the future of drug discovery.  \n\n\n\nBy streamlining research processes and addressing current weaknesses related to sub-optimal workflows and time-consuming manual tasks\, AI solutions have the potential to deliver a drug candidate within 24 months with just two chemists and one robot\, a significant reduction compared to the conventional requirement of 10 people and 30 months. \n\n\n\nInvite your entire Team to attend this FREE webinar\, including your scientists\, researchers\, R&D leads and business development professionals! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nQuentin Perron\, Ph.D.Co-Founder & Chief Scientific Officer\, Iktos \n\n\n\nAfter completing his post-doc fellowship at UCLA where Dr. Perron worked on the total synthesis of Brasillicardin A\, a complex natural molecule known for having a potent immunosuppressive activity\, he was a medicinal chemist in CNS indications at Laboratoires Servier. He later switched to data science and chemoinformatics at Quinten\, a company specialized in data science services. In 2016\, with his business partners Yann Gaston-Mathé and Nicolas Do Huu\, Dr. Perron co-founded Iktos\, a start-up company developing AI technologies for new drug design. \n\n\n\n\n\n\n\n\n\nFranck Le Vaillant\, Ph.D.\, MBASenior Scientist & Deputy Lab Head\, Iktos \n\n\n\nUpon completion of his Ph.D.\, Dr. Le Vaillant became a SNF-postdoctoral fellow to the Max-Planck-Institute für Kohlenforschung in Mülheim an der Ruhr where he developed Ni-catalyzed C-O bond formations using nitrous oxide. He later started the Labcom HitCat\, a joint lab between the company Seqens and the group of Prof. Géraldine Masson (CNRS). Dr. Le Vaillant joined Iktos in July 2022\, where he works on the installation\, development and utilization of the Iktos Robotics Platform for Drug Discovery. \n\n\n\n\n\n\n\n\nWe hope to see you on March 6\, 2024 for this FREE educational webinar. URL:https://bionj.org/event/integrating-ai-and-robotics-to-discover-new-drugs-faster/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240208T164500 DTEND;TZID=America/New_York:20240208T213000 DTSTAMP:20260503T084720 CREATED:20231129T132752Z LAST-MODIFIED:20241120T151605Z UID:9813-1707410700-1707427800@bionj.org SUMMARY:2024 BioNJ Annual Dinner Meeting & Innovation Celebration DESCRIPTION:Thursday\, February 8\, 2024 | 4:45 p.m.-9:30 p.m. | Hilton East Brunswick\n\n\n\n\nBecome a Sponsor\n\n\n\nPhoto Gallery\n\n\n\n\nWe are excited to share that due to popular demand\, BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration is sold out! Thank you to everyone who has registered to attend tomorrow’s celebration. We look forward to paying tribute to New Jersey’s extraordinary life sciences ecosystem and the Patients who inspire us. Registration is now closed and we are unable to accommodate walk-ins. We apologize for any inconvenience. Please contact BioNJ at 609-890-3185 with any questions. Thank you for your support and understanding. \n\n\n\n\n\n\n\nJoin us for BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration\, taking place Thursday\, February 8\, 2024\, at the Hilton East Brunswick\, where we’ll celebrate the extraordinary innovation happening in the Garden State.   \n\n\n\nMany surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year\, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:  \n\n\n\n\nNetworking with biopharmaceutical professionals\, government officials\, academic leaders and professional service providers\n\n\n\nThe presentation of the Dr. Sol J. Barer Award for Vision\, Innovation and Leadership by Dr. Barer himself to William H. Lewis\, J.D.\, MBA\, Chair and CEO of Insmed\n\n\n\nAn inspirational Spoken Word by Lupus Warrior Shanelle Gabriel\n\n\n\nThe acclaimed Innovator Awards honoring New Jersey companies that received a new FDA drug approval in 2023\n\n\n\nThe presentation of the Heart of BioNJ Awards to Lisa Salberg\, Founder & CEO\, Hypertrophic Cardiomyopathy Association; Amadou Diarra\, Ph.D.\, Senior Vice President\, Global Policy\, Advocacy & Government Affairs\, Bristol Myers Squibb and Mark Peters\, Senior Director\, Patient Advocacy\, Genmab \n\n\n\nA special Keynote honoring Patients around the world\n\n\n\nA Cocktail Hour\, Dinner Program and Dessert Reception\n\n\n\n\nDon’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $500 and $575 for Future Members. Reserve a table for your Team today.  \n\n\n\nThe 2024 Innovator Award Honorees Include: \n\n\n\n\n\n\nAbbVie \n\n\n\nAcrotech Biopharma \n\n\n\nAmicus Therapeutics \n\n\n\nAcadia Pharmaceuticals \n\n\n\nBausch + Lomb\n\n\n\nBristol Myers Squibb \n\n\n\nCorMedix Inc. \n\n\n\nDaiichi Sankyo \n\n\n\nEisai \n\n\n\nEli Lilly \n\n\n\nEvive Biotech \n\n\n\nGamida Cell\n\n\n\nGC Biopharma USA \n\n\n\nGenmab\n\n\n\nGSK \n\n\n\nIpsen\n\n\n\n\n\n\n\nIveric BIO\n\n\n\nJohnson & Johnson\n\n\n\nLexicon Pharmaceuticals\n\n\n\nMelinta Therapeutics \n\n\n\nNestlé Health Science \n\n\n\nNovartis\n\n\n\nNovo Nordisk \n\n\n\nOctapharma\n\n\n\nProtalix Biotherapeutics\n\n\n\nPfizer \n\n\n\nPharming \n\n\n\nRegeneron\n\n\n\nSanofi \n\n\n\nPlus\, Boehringer Ingelheim Animal Health USA and Zoetis for FDA Animal Drug Approvals\n\n\n\n\n\n\n\n\n\n\n\n\n\nContact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities\, reserve a table and to place your organization in the spotlight.  URL:https://bionj.org/event/2024-annual-dinner-meeting-innovation-celebration/ LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240118T120000 DTEND;TZID=America/New_York:20240118T130000 DTSTAMP:20260503T084720 CREATED:20231212T181900Z LAST-MODIFIED:20231218T194037Z UID:9888-1705579200-1705582800@bionj.org SUMMARY:How End-User Adoption is Key to Software Deployment Success DESCRIPTION:FREE Webinar: How End-User Adoption is Key to Software Deployment Success \n\n\n\nThursday\, January 18\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this intimate discussion with industry leaders on best practices to ensure end-user adoption in software project deployment. Topics to be covered include: \n\n\n\n\nUsing an MVP (Minimum Viable Product) strategy under the guidance of a seasoned business analyst to meet crucial end-user requirements.\n\n\n\nEmploying Agile methodology for continuous feedback and improvement.\n\n\n\nControlling scope and managing expectations through phased rollouts.\n\n\n\nReflecting on past challenges and successes.\n\n\n\n\nInvite your entire Project Team to attend this FREE webinar\, created for project managers\, business analysts\, engineering\, IT end-users\, operators\, scientists and more! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nAnthony DeJohnDirector\, Systems & Software SolutionsControl Associates \n\n\n\nMr. DeJohn boasts a successful 30-year career in process control\, digital manufacturing and process data analytics technologies\, establishing himself as a prominent process automation leader.  Passionate about manufacturing excellence\, digital tools\, and leveraging data from the shop floor to enterprise systems\, Mr. DeJohn remains at the forefront of innovation in the industry. \n\n\n\n\n\n\n\n\n\nPaula HudsonSenior Lab Systems ArchitectThermo Fisher Scientific \n\n\n\nMs. Hudson has accumulated over 20 plus years’ experience as a concept-to-launch project manager\, application designer\, data analyst\, database architect and application support expert. Through her work at universities and with one of the largest pharmaceutical manufacturers in the world\, she is recognized for her ability to guide impactful change.  \n\n\n\n\n\n\n\n\n\nSusanne BrownVice President\, Program ManagementInsmed \n\n\n\nMs. Brown works with a team of talented program managers to support and drive excellence in drug development bringing new promising medications to Patients.  After spending time in the microbiology lab and running clinical development programs\, she decided to dedicate her career in all avenues of project\, program\, resource and portfolio management. Prior to Insmed\, Ms. Brown held various roles at several large pharmaceutical and Healthcare companies \n\n\n\n\n\n\n\n\nWe hope to see you on January 18\, 2024 for this FREE educational webinar. URL:https://bionj.org/event/how-end-user-adoption-is-key-to-software-deployment-success/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231207T120000 DTEND;TZID=America/New_York:20231207T130000 DTSTAMP:20260503T084720 CREATED:20231031T140557Z LAST-MODIFIED:20231115T153551Z UID:9584-1701950400-1701954000@bionj.org SUMMARY:BioNJ Health Equity in Clinical Trials Best Practices Webinar DESCRIPTION:BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Designing Trials to Broaden Reach and Expand Diversity\n\n\n\nThursday\, December 7\, 2023 | 12:00 p.m. – 1:00 p.m. | Free Webinar\n\n\n\n\nRegister Today!\n\n\n\nHealth Equity in Clinical Trials Best Practices Database\n\n\n\n\nBioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end\, we are pleased to announce the second webinar in BioNJ’s Health Equity in Clinical Trials Best Practices Webinar Series. Please join us on Thursday\, December 7\, from 12:00 p.m. to 1:00 p.m.\, as three industry experts share case studies on methods and techniques which their organizations use to “Broaden Reach and Expand Diversity in Clinical Trials.” \n\n\n\nPresenters include: \n\n\n\n\n\n\n\n\nMichel Reid\, Senior Director and Head\, Global Demographics & Diversity for GSK\, will present on My Living Legacy\, created in partnership with the Tigerlily Foundation to empower Black and other BIPOC people to more deeply understand and trust in clinical trials and to consider clinical trials as a possible treatment option for life-threatening diseases like breast cancer. Mr. Reid will also share how GSK partnered with MiOrato ensure that women from underserved communities are represented in clinical trials for Ovarian Cancer by training public health student in socioeconomically disadvantaged neighborhoods to become community health educators.  \n\n\n\n\n\n\n\n\n\nThe FDA defines a decentralized clinical trial as a clinical investigation where some or all of the trial-related activities occur at a location separate from the investigator’s location. Today’s technologies let Patients remotely engage with trial activities\, creating better Patient experiences and letting sponsors execute faster trials – driven by high-quality data. Kelly McKee\, Vice President\, Decentralized Clinical Trials\, for Medidata\, will present on how to use decentralized trialsto broaden reach and improve Patient\, site and sponsor experiences. Using a case study\, Ms. McKee will explore what decentralized clinical trials mean for all stakeholders\, including biopharmaceutical companies. \n\n\n\n\n\n\n\n\n\nSunanda Gaur\, M.D.\, Director of the Clinical Research Center at Rutgers Robert Wood Johnson Medical School\, will share valuable insights into Rutgers’ four-year study on the long-term and delayed impacts of COVID-19 in children. Encompassing more than 2\,000 participants\, across 14 sites\, Dr. Gaur will discuss Rutgers’ community-facing strategy\, including bi-lingual recruitment leads\, used for trial enrollment. Additionally\, Dr. Gaur will elaborate on the decentralize component of the trial to ensure inclusion of diverse populations.  \n\n\n\n\n\n\n\n\nRegister for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and ensure that “No Patient is ever left behind“. URL:https://bionj.org/event/bionj-health-equity-in-clinical-trials-best-practices-webinar-2/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231201T083000 DTEND;TZID=America/New_York:20231201T150000 DTSTAMP:20260503T084720 CREATED:20230717T182336Z LAST-MODIFIED:20231129T122115Z UID:7820-1701419400-1701442800@bionj.org SUMMARY:2023 Inspiring Women in STEM Conference DESCRIPTION:Empowering Brilliance & Resilience for Long-Term Success\n\n\n\nFriday\, December 1\, 2023 | Sanofi U.S.\, 55 Corporate Drive\, Bridgewater\, NJ \n\n\n\nJoin us for BioNJ’s Ninth Annual Inspiring Women in STEM Conference on Friday\, December 1\, 2023. The action-packed schedule features forward-thinking presentations\, informative panel discussions\, audience participation exercises and quality networking.  \n\n\n\nMore timely than ever\, attendees are sure to come away with valuable and actionable ideas and guidance! \n\n\n\n\n\n\n\n\nDon’t Miss This Special Keynote \n\n\n\nBe UNFORGETTABLE: How to Position Yourself for Success \n\n\n\nPresented by Alessandra Wall\, Ph.D.\, Executive Coach\, Speaker\, Founder\, Noteworthy \n\n\n\nImagine stepping into any situation and feeling 100% confident in your ability to articulate your value and the impact you can make for your team\, your company\, a client or a prospective employer. This keynote explores three fail-proof strategies to position yourself to do more of what you excel at and love. You will discover a process to confidently share your areas of excellence with others and help them understand the impact you can make for them and your organizations. You’ll develop a blueprint to speak up\, own your power and value and share it with others without guilt or unease ― and become UNFORGETTABLE! \n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\nClick here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions.   URL:https://bionj.org/event/2023-inspiring-women-in-stem-conference/ LOCATION:Sanofi\, Sanofi Building D\, Corporate Dr\, Bridgewater Township\, NJ\, 08807 CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/07/IWSTEM.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231116T083000 DTEND;TZID=America/New_York:20231116T141500 DTSTAMP:20260503T084720 CREATED:20230809T152945Z LAST-MODIFIED:20230918T163650Z UID:8176-1700123400-1700144100@bionj.org SUMMARY:2023 BioNJ Patient Advocacy Summit DESCRIPTION:Thursday\, November 16\, 2023\, 8:30 a.m.-2:15 p.m.\n\n\n\nBristol Myers Squibb • 3551 Lawrenceville Rd\, Princeton\, NJ 08540 \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nIn its eighth year\, BioNJ’s Patient Advocacy Summit is taking place November 16 at Bristol Myers Squibb. With topics requested by the Patient advocacy community\, we hope you join us for this important conversation! Please check out the agenda below and click here to register. \n\n\n\nThe Summit will bring together Patients\, Patient Advocacy Groups\, Caregivers\, Clinicians and R&D Professionals for a day of Education\, Engagement and Empowerment. Attendees will gain valuable tools and insights\, share best practices and meet key stakeholders within the health care ecosystem.  \n\n\n\nJoin us for this dynamic and educational discussion that will leave us all inspired and armed with new tools to make a difference on behalf of Patients! \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nA must attend program for anyone who advocates on behalf of Patients! Click here to register! Attendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\nPlus\, if you are unable to attend in person\, and are interested in watching a live streamed version of the event\, please contact Randi Bromberg at RBromberg@BioNJ.org. URL:https://bionj.org/event/2023-bionj-patient-advocacy-summit/ LOCATION:Bristol Myers Squibb\, 3551 Lawrenceville Rd\, Princeton\, New Jersey\, 08540\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/BioNJ_PPA-Summit_Logo_copy-copy.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231101T130000 DTEND;TZID=America/New_York:20231101T180000 DTSTAMP:20260503T084720 CREATED:20230828T175346Z LAST-MODIFIED:20231003T201630Z UID:8643-1698843600-1698861600@bionj.org SUMMARY:2023 AI & Digital Health Day DESCRIPTION:Wednesday\, November 1\, 2023 • 1:00 p.m. – 6:00 p.m. \n\n\n\n340 Mt. Kemble Ave\, Morristown \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nAI is rapidly changing the way we do things in the workplace\, and the impact in the life sciences industry has been both rapid and significant. BioNJ\, in partnership with Morgan Stanley\, will host its inaugural BioNJ AI & Digital Health Day on November 1. \n\n\n\nJoin us for this important program which will: \n\n\n\n\nHighlight emerging trends within the life sciences industry\n\n\n\nProvide access to investors\, thought leaders and experts for advice and guidance\n\n\n\nAddress some of the challenges that entrepreneurs face as they create innovative AI and digital health solutions to improve Patient outcomes\n\n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nSPACE IS LIMITED! Register today and join an audience of entrepreneurs and industry professionals that support the life sciences and digital health ecosystem for this timely and informative discussion. Registration is $25 for BioNJ Members and $35 for Future Members. Click here to register. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. URL:https://bionj.org/event/2023-ai-digital-health-day/ LOCATION:Morgan Stanley\, 340 Mt. Kemble Ave.\, New Jersey\, 07960\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/AI-Digital-Health-Color-With-Sponsors-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231026T090000 DTEND;TZID=America/New_York:20231026T160000 DTSTAMP:20260503T084720 CREATED:20230810T164457Z LAST-MODIFIED:20230901T134049Z UID:8202-1698310800-1698336000@bionj.org SUMMARY:INDUSTRY EVENT: BioLabs Investor Day 2023 Princeton DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\n\nBioLabs is planning an Investor Day on Thursday\, October 26\, from 9 am to 4 pm\, with the goal of bringing a wide range of investors to Princeton for a day of pre-selected lightning pitches\, a panel discussion and invite-only networking.  \n\n\n\nBioLabs held successful Investor Day events at our sister sites in Heidelberg\, Germany\, and Philadelphia\, Pennsylvania\, including an event in Chicago\, Illinois\, as well. These events helped make connections across the life science community at a time when it matters more than ever — featuring 10–30 pitches and 25–30 investors per event. The Princeton event will target an invite-only audience of >100 select attendees.   \n\n\n\nIf interested in attending\, please fill out this form.  \n\n\n\nJoin us in bringing our winning formula to Princeton on October 26! URL:https://bionj.org/event/biolabs-investor-day-2023-princeton/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231026T090000 DTEND;TZID=America/New_York:20231026T120000 DTSTAMP:20260503T084720 CREATED:20230717T180640Z LAST-MODIFIED:20231024T175020Z UID:7818-1698310800-1698321600@bionj.org SUMMARY:2023 IT/Cybersecurity Breakfast Briefing DESCRIPTION:Navigating the Digital Frontier: Empowering Your Cybersecurity Journey\n\n\n\nThursday\, October 26 2023 • 9:00 a.m. – 12:00 p.m.Fox Hollow Golf Club\, 59 Fox Chase Run\, Branchburg\, NJ 08876\n\n\n\n \n\n\n\n\nRegister Now\n\n\n\nBecome a Sponsor\n\n\n\n\nThe life sciences industry continues to be a top target for cyber criminals. So much so that bad cyber actors are infiltrating the unintended IT weaknesses of the 3rd-party vendor community that is so supportive of life sciences companies.  \n\n\n\nWhether a life sciences company is pre-revenue\, early-revenue or mature\, this 3rd-party vendor vulnerability puts all data at risk\, including\, but not limited to\, data related to patients\, research\, intellectual property and M&A.  \n\n\n\nTo help address this and other cybersecurity challenges\, please join us at Fox Hollow Golf Club in Branchburg on October 26th for a BioNJ IT/Cybersecurity Awareness Breakfast Briefing. We will network\, have breakfast and hear from the FBI and other experts about practical and cost-effective tips to better protect your organization’s data. \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nDiscounted golf is offered after the program. 9 holes of golf with a cart available for $30 per golfer. Tee-time reservations are required. To make a reservation call (908)-526-0010\, Ext. 102. \n\n\n\n\n\n\nRegistration is $75 for BioNJ Members and $95 for Future Members. If you would like to learn about Sponsorship Opportunities\, please contact Cheri Hennessy at CHennessy@BioNJ.org.  URL:https://bionj.org/event/2023-it-cybersecurity-breakfast-briefing/ LOCATION:Fox Hollow Golf Club\, 59 Fox Chase Run\, Branchburg\, New Jersey\, 08876\, United States CATEGORIES:BioNJ Event ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/IT-Cyber.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231019T120000 DTEND;TZID=America/New_York:20231019T131500 DTSTAMP:20260503T084720 CREATED:20230922T152558Z LAST-MODIFIED:20231016T110144Z UID:9056-1697716800-1697721300@bionj.org SUMMARY:2023 Finance Webinar DESCRIPTION:Bridging Science and Finance: Practical Uses of AI\n\n\n\nThursday\, October 19\, 2023 • 12:00 p.m. – 1:15 p.m. • Virtual\n\n\n\n\nRegister Now\n\n\n\n\nJoin us for a dynamic webinar that delves into the role of AI in financial operations in life sciences. We’ll explore how technologies are reshaping financial strategies and decision-making as well as hear about real-life examples. Gain insights into the evolving landscape of AI-driven finance while discovering key trends\, challenges and opportunities that are driving financial innovation. We’ll hear about best practices in leveraging AI and the benefits it can provide to finance teams and the organization as a whole to achieve financial excellence in life sciences. \n\n\n\nPanel of Experts: \n\n\n\n\n\n\n\nWhether you’re a financial professional\, a life sciences executive or simply curious about the future of finance in the healthcare sector\, this free webinar offers a unique opportunity to gain knowledge and inspiration on the benefits AI can offer from industry experts. Don’t miss your chance to be a part of this enlightening conversation at the intersection of finance\, AI and medical innovation. Click here to register at no cost. URL:https://bionj.org/event/2023-finance-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/07/IWSTEM.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231015T000000 DTEND;TZID=America/New_York:20231018T235959 DTSTAMP:20260503T084720 CREATED:20230711T134325Z LAST-MODIFIED:20230901T134017Z UID:7733-1697328000-1697673599@bionj.org SUMMARY:Winds of Change 2023 DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\n\nThe LES USA & Canada 2023 Annual Meeting will take place at the trendy Chicago Marriott Downtown Magnificent Mile\, October 15-18\, 2023. Under the theme of Winds of Change: Dealmaking Trends in the Evolving Innovation Economy\, our dynamic international IP community will meet in Chicago for two action-packed days of education\, outstanding programming\, and networking\, with global dealmaking opportunities.  \n\n\n\nThe 2023 Annual Meeting will include distinguished keynotes and fireside chats along with forward-looking topics\, ranging from advances in healthcare\, smart manufacturing\, innovations in fintech\, and IP valuation in the new era of licensing. Join interactive roundtable discussions or the partnering hub to expand your business network! \n\n\n\nRegister today and reconnect with friends and peers over coffee\, make new contacts during networking events and receptions and so much more at the LES 2023 Annual Meeting. \n\n\n\nLearn more and register. URL:https://bionj.org/event/winds-of-change/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231012T100000 DTEND;TZID=America/New_York:20231012T113000 DTSTAMP:20260503T084720 CREATED:20231003T143822Z LAST-MODIFIED:20231003T145410Z UID:9120-1697104800-1697110200@bionj.org SUMMARY:Road to Commercialization Symposium Series: Communicating with Impact and the Art of Storytelling DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\nRutgers Office for Research extends our invitation to the NJ researchers and entrepreneurs ecosystem to join us on Thursday\, Oct 12\, from 10 am-11.30 am (EST) for our Road to Commercialization Webinar\, Communicating with Impact: The Art of Storytelling. Hear from keynote speakers Otto Pohl and Dena Seidel who will share their expertise\, do’s and don’ts and tested framework/s to help us tell the story of our research effectively and in a way that is meaningful to industry and investors and others listening to it. To learn more about this webinar\, click here. Feel free to share with anyone you think might be interested as this event is open to all. URL:https://bionj.org/event/road-to-commercialization-symposium-series-communicating-with-impact-and-the-art-of-storytelling/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231006T073000 DTEND;TZID=America/New_York:20231006T160000 DTSTAMP:20260503T084720 CREATED:20230221T141436Z LAST-MODIFIED:20231005T125458Z UID:6712-1696577400-1696608000@bionj.org SUMMARY:2023 BioNJ C-Suite Summit DESCRIPTION:Registration for the C-Suite Summit is closed.  Please contact BioNJ Headquarters at 609-890-3185 with any questions or to be added to a wait list. \n\n\n\n\n\n\n\nChasing Breakthrough Innovation in a Time of UncertaintyWith Insights from McKinsey & Company\n\n\n\nFriday\, October 6\, 2023 • 7:30 a.m.-4:00 p.m.Bridgewater Marriott\, 700 Commons Way\, Bridgewater\n\n\n\n\nBecome a Sponsor\n\n\n\n2022 Attending Companies\n\n\n\n\nWe are facing a period of discontinuous change marked by the ever-accelerating AI revolution and advancements in therapeutics ― set against the backdrop of increasing lifecycle compression (exacerbated by the Inflation Reduction Act)\, a tumultuous fundraising environment\, and growing macroeconomic uncertainty. \n\n\n\nJoin BioNJ and industry leaders on October 6 to explore the implications of these evolutions\, with a focus on the trajectory of breakthrough innovation. In addition to timely topics\, such as a futuristic look at innovation\, reimagining the biopharma workforce and the transformative impact of technology and AI on the industry\, be on hand for these Keynotes… \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nClick here to register. Registration is $695 for BioNJ Members and $895 for future BioNJ Members. BioNJ’s C-Suite Summit brings together more than 200 life sciences executives ― representing a wide breadth of companies from early to late-stage\, public and private and revenue and pre-revenue ― for networking and timely discussions on what’s impacting C-Suite decision-making in bringing new innovation to market. \n\n\n\nSponsorship opportunities are now available. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn more. URL:https://bionj.org/event/bionj-c-suite-summit/ LOCATION:Bridgewater Marriott\, 700 Commons Way\, Bridgewater\, New Jersey\, 08807\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/02/CSuite-Summit-2023.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230928T170000 DTEND;TZID=America/New_York:20230928T190000 DTSTAMP:20260503T084720 CREATED:20230817T182243Z LAST-MODIFIED:20230901T133733Z UID:8494-1695920400-1695927600@bionj.org SUMMARY:Science Matters: New Jersey Newcomers Blazing Trails DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\nRegister URL:https://bionj.org/event/science-matters-new-jersey-newcomers-blazing-trails/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230927T090000 DTEND;TZID=America/New_York:20230927T100000 DTSTAMP:20260503T084720 CREATED:20230901T120503Z LAST-MODIFIED:20230925T162839Z UID:8711-1695805200-1695808800@bionj.org SUMMARY:Webinar: The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven\, Compliant\, Equitable\, Connected Healthcare Ecosystem DESCRIPTION:The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven\, Compliant\, Equitable\, Connected Healthcare Ecosystem\n\n\n\nWednesday\, September 27\, 2023 ● 9:00 a.m.-10:00 a.m.\n\n\n\n\nRegister Today\n\n\n\n\nThe speed of innovation and acceleration in healthcare is nothing like we have ever seen before. The industry was picking up speed prior to the COVID-19 pandemic and since then we have seen an acceleration in everything from telemedicine\, to decentralized clinical trials\, to AI applied to everything from drug discovery to commercialization. That leaves us both with an amazing opportunity to solve some of the greatest healthcare challenges but also brings new complexities and issues we need to tackle from a privacy\, security\, legal and ethical standpoint. It will take everyone to both realize the potential and ensure we move forward in a measured and responsible way that does not hold back the very innovation that will save lives – why we all do what we do every day! \n\n\n\nJoin BioNJ and industry leaders on September 27 to dive into these topics with a focus on how we can all start to apply new technologies even in the smallest ways to make progress forward in what will prove to be one of the most dynamic eras of healthcare ahead.  \n\n\n\n\n\n\n\n\n Reed Abrahamson\, Partner\, Faegre Drinker \n\n\n\nAs a member of Faegre Drinker’s FDA Regulatory Team\, Reed advises clients in the life sciences industry\, including major pharmaceutical\, biotechnology and medical device companies\, on a wide range of issues associated with clinical trials and research. He assists in the development and negotiation of clinical trial agreements\, informed consent forms and other important research documents. Additionally\, Reed supports companies as they contract with research vendors and collaboration partners\, as well as helps companies implement privacy and security measures to support clinical trials and medical research. \n\n\n\n\n\n\n\n\n\n Lynne Anderson\, Partner\, Faegre Drinker \n\n\n\nLynne has a long history of working with life sciences/pharmaceutical clients. She is an experienced jury and bench trial lawyer with a track record of success in whistleblower/retaliation cases\, discrimination claims\, wage and hour class/collective actions and restrictive covenant disputes. Lynne’s litigation background provides the insight to effectively counsel clients who are dealing with strategic planning and frontline employee issues. She is Co-Chair of the BioNJ’s HR Committee and founding member and Co-Chair of BioNJ’s Inspiring Women of STEM Committee. \n\n\n\n\n\n\n\n\n\n Romain Bogaerts\, Director\, AI Product Management\, Real Chemistry \n\n\n\nRomain’s team builds both internal facing AI solutions and external AI products for life sciences companies. Internally\, the team has developed a Generative AI platform and other AI algorithms that empower the agency side of Real Chemistry to become exponentially more insightful. For clients\, Romain leads the design and development of innovative products: AdTech capabilities for Swoop to target the right Patient and HCP audiences\, HealthTech products at ipm.ai to identify undiagnosed Patients in specialty and MarTech data products that link SDOH and social media data to measure the impact of campaigns. \n\n\n\n\n\n\n\n\n\n Jennifer Gottlieb\, Global President\, Chief Client Officer\, Real Chemistry \n\n\n\nJennifer is the Global President\, Chief Client Officer and member of the Board of Directors of Real Chemistry\, the leading provider of AI-driven insights and human-centric experiences for the healthcare industry. A healthcare pioneer — Jennifer’s career has been dedicated to driving strategic communications and commercial initiatives for clients in the pharmaceutical and biotechnology sectors as they navigate the ever-changing industry landscape. Jennifer takes on bold challenges\, including realizing the company’s vision to use AI and Ideas to transform the healthcare experience from what it is to what it should be. \n\n\n\n\nWe hope to see you on September 27 for this FREE educational webinar! URL:https://bionj.org/event/webinar-the-technology-revolution-in-healthcare-is-in-sight-realizing-an-ai-driven-compliant-equitable-connected-healthcare-ecosystem/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/09/Webinar-Banner-Faegre.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230925T000000 DTEND;TZID=America/New_York:20230927T235959 DTSTAMP:20260503T084720 CREATED:20230726T181257Z LAST-MODIFIED:20230901T133736Z UID:7942-1695600000-1695859199@bionj.org SUMMARY:Life Sciences Palooza 2023 DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\nPlay your cards right and join us at Life Sciences Palooza 2023!\n\n\n\nJoin valued customers from RLDatix Life Sciences\, including Porzio Life Sciences\, iContracts\, and iCoachFirst. You’ll gain the insight and inspiration you need to take your initiatives to the next level. \n\n\n\nTaking place from the afternoon of September 25th through 27th at the Hard Rock Hotel in Atlantic City\, we will provide a robust schedule of thought-provoking keynotes\, immersive hands-on discussion points\, lively evening networking activities and so much more.  \n\n\n\nHIGHLIGHTS: \n\n\n\n\nOverview of current Industry Trends\n\n\n\nBest Practices for Reporting\, Analyzing Data\, Integrating Compliance\, and more…\n\n\n\nProduct-Specific Breakout Groups\n\n\n\nFun\, Games\, and Surprise Guests!\n\n\n\n\nQuestions? Contact Lexi (Harris@porziols.com) or Kristen (kabrahamsen@icontracts.com).  \n\n\n\n\nRegister URL:https://bionj.org/event/life-sciences-palooza-2023/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230921T123000 DTEND;TZID=America/New_York:20230921T133000 DTSTAMP:20260503T084720 CREATED:20230804T105609Z LAST-MODIFIED:20230924T130445Z UID:8037-1695299400-1695303000@bionj.org SUMMARY:BioNJ Health Equity in Clinical Trials Best Practices Webinar DESCRIPTION:BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration\n\n\n\nThursday\, September 21\, 2023 • 12:30 p.m.-1:30 p.m. | Free Webinar\n\n\n\n\nRegister Today!\n\n\n\nHealth Equity in Clinical Trials Best Practices Database\n\n\n\n\nBioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end\, we are pleased to announce the highly anticipated next phase of our work in a series of programs where life sciences professionals can share their health equity in clinical trials initiatives\, ask questions and explore possible collaboration opportunities. \n\n\n\nOn the heels of our recently debuted Best Practices Database featuring a diverse array of initiatives being offered by the community\, please join us virtually on Thursday\, September 21\, from 12:30 p.m. to 1:30 p.m.\, for BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration. Click here to register for FREE. \n\n\n\nLearn about three innovative initiatives which have the potential to be game changers: \n\n\n\n\n\n\n\n\n Bristol Myers Squibb \n\n\n\nIn looking beyond race and ethnicity\, Bristol Myers Squibb (BMS) is partnering with its Employee Resource Groups to explore diversity in clinical trials as it impacts other groups. Sharon Hanlon\, Head of Clinical Trials Engagement and Enrollment\, will discuss two recent BMS initiatives: “SOGIIS Data Collection Patients” which gives Patients the option to report demographic information relevant to their sexual orientation and gender identity and a “Clinical Trials Implications Assessment for Disabled Patients” which journey maps the clinical trial experience for disabled Patients\, identifying opportunities for growth. \n\n\n\n\n\n\n\n\n\n Novartis & U.S. Novartis Foundation \n\n\n\nNovartis and the U.S. Novartis Foundation have taken a major step forward in addressing the root causes of disparities in health and education with Beacon of Hope – a 10-year commitment to co-creating programs that address health and education inequities and create greater diversity\, equity\, inclusion and trust across the research and development ecosystem. Dr. Linda Armstrong\, Head of U.S. Corporate Responsibility and President of U.S. Novartis Foundation\, will provide an overview of this first-of-its-kind innovative collaboration with 26 Historically Black Colleges and Universities\, Merck\, Sanofi\, Amgen\, Alnylam\, the Global Black Economic Forum\, the National Medical Association\, Thurgood Marshall College Fund\, Coursera\, Advarra\, Virb and BeeKeeperAI. \n\n\n\n\n\n\n\n\n\n Janssen Pharmaceuticals \n\n\n\nJanssen’s “Research Includes Me” initiative seeks to identify needs\, build trust and break down barriers to access with a focus on traditionally underrepresented communities by providing educational materials\, addressing misperceptions\, hosting community events and connecting Patients to clinical research opportunities. Staci Hargraves\, Vice President of Portfolio Delivery Operations\, Global Development\, will share how Janssen partnered with industry groups\, such as the Society of Clinical Research Sites Diversity Awareness Program and Transcelerate’s Diversity in Clinical Trials workstream\, to develop programs and tools that foster better Patient experiences and care. \n\n\n\n\n\n\n\n\nRegister for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and to ensure that “No Patient is ever left behind”. URL:https://bionj.org/event/bionj-health-equity-in-clinical-trials-best-practices-webinar/ LOCATION:New Jersey CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230913T083000 DTEND;TZID=America/New_York:20230913T153000 DTSTAMP:20260503T084720 CREATED:20230309T001446Z LAST-MODIFIED:20230912T095135Z UID:7057-1694593800-1694619000@bionj.org SUMMARY:2023 BioNJ Manufacturing Briefing DESCRIPTION:Registration is now closed. Please email MCarapucci@BioNJ.org to be added to our waiting list. \n\n\n\n\n\n\n\nRising to the Challenge: Manufacturing & Supplying Therapies in Today’s Reality\n\n\n\nWednesday\, September 13\, 2023 • 8:30 a.m.-3:30 p.m.\n\n\n\nRutgers University\, Busch Campus Student Center • 604 Bartholomew Road\, Piscataway\, NJ 08854 \n\n\n\n\nBecome a Sponsor\n\n\n\n\nBiopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry\, such as Controlling the Cost of Goods; Digital\, Automation and AI in Biotech Manufacturing; and Strategic Partnerships with CMOs and CDMOs. Plus\, be on hand for… \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\n\n\nStay after the program to tour Rutgers Pharma Manufacturing Facility ─ The two-story\, state-of-the-art continuous manufacturing lab is a $2 million dollar facility built with funding from the National Science Foundation that is providing biopharmaceutical manufacturers with an alternative to traditional batch processing\, including efficiencies that improve quality\, consistency\, production speed and cost. (Tour is on a first-come\, first-serve basis and number of participants is limited.) \n\n\n\nBe sure to forward this email to colleagues and customers who could also benefit from these topical discussions and perspectives! Registration is $95 for BioNJ Members and $175 for Future Members. Click here to register. URL:https://bionj.org/event/bionj-manufacturing-briefing/ LOCATION:Rutgers University\, Busch Campus Student Center\, 604 Bartholomew Road\, Piscataway\, New Jersey\, 08854\, United States CATEGORIES:BioNJ Event,Entrepreneurs-Exchange ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/03/Manufacturing-Briefing-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230830T000000 DTEND;TZID=America/New_York:20230830T235959 DTSTAMP:20260503T084720 CREATED:20230719T124306Z LAST-MODIFIED:20230901T133815Z UID:7824-1693353600-1693439999@bionj.org SUMMARY:2023 TIE Women's Pitch Competition DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\n\n Aug 30\, 2023 \n\n\n\n 06:00 PM – 09:00 PM (America/New_York) \n\n\n\n New Jersey Bioscience Center\, 675\,U.S. 1 \n\n\n\n North Brunswick Township\,United States \n\n\n\n $25 onwards \n\n\n\n\nRegister URL:https://bionj.org/event/2023-tie-womens-pitch-competition/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230706T000000 DTEND;TZID=America/New_York:20230706T235959 DTSTAMP:20260503T084720 CREATED:20230208T131308Z LAST-MODIFIED:20230209T180810Z UID:6428-1688601600-1688687999@bionj.org SUMMARY:On Helix - New Horizons for Bio Innovation DESCRIPTION:www.onhelix.com \n\n\n\n\n\nThis one-day conference will address key bio innovation trends\, from developments in life science and technology research to their translation into new diagnostics\, prevention tools or treatments. \n\n\n\nDelegates and Supporters will connect with the One Nucleus network to explore New Horizons for Bio Innovation. \n\n\n\nON Helix Key Benefits: \n\n\n\n\nHigh content mix of plenary talks and panels from key opinion leaders\n\n\n\nNetworking with 250+ delegates on the day\n\n\n\nOption to arrange 1 to 1 virtual meetings with in-person and digital only delegates\n\n\n\nThe ON Helix Fringe events including digital Innovation Workshops for further technical and business insights and additional in-person networking opportunities \n\n\n\nThe Innovation Support Hub Exhibition\, to showcase the most innovative early-stage life science companies as well as the innovation supporters from the network URL:https://bionj.org/event/on-helix-new-horizons-for-bio-innovation/ LOCATION:New Jersey CATEGORIES:Industry Event END:VEVENT END:VCALENDAR